Effect of empagliflozin treatment on laboratory and clinical findings of patients with glycogen storage disease type Ib: first study from Türkiye
This study revealed empagliflozin to be effective in improving the neutrophil counts of patients with GSD Ib and in enhancing the QoL of both the patients and their caregivers.
Authors
- Engi̇n Köse (ORCID: https://orcid.org/0000-0001-7238-2894)
- Halil İbrahim Aydın (ORCID: https://orcid.org/0000-0001-7994-4394)
- Leyla Tümer (ORCID: https://orcid.org/0000-0002-7831-3184)
- Figen Özçay (ORCID: https://orcid.org/0000-0002-5214-516X)
- Çiğdem Seher Kasapkara (ORCID: https://orcid.org/0000-0002-3569-276X)
- Fatma Tuba Eminoğlu (ORCID: https://orcid.org/0000-0002-5880-1113)
- Aynur Küçükçongar Yavaş (ORCID: https://orcid.org/0000-0002-4766-300X)
- Aslı İnci (ORCID: https://orcid.org/0000-0002-0561-2060)
Institutions
- Ankara University (TR)
- Başkent University (TR)
- Memorial Ankara Hospital (TR)
- Ankara Yıldırım Beyazıt University (TR)
- Gazi University (TR)
Publication Details
- Journal
- Journal of Pediatric Endocrinology and Metabolism
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1515/jpem-2024-0556
- Citations
- 2
- Primary Topic
- Glycogen Storage Diseases and Myoclonus
- Type
- article
- Field-Weighted Citation Impact
- 3.34